These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 23240851)

  • 21. Convection-Enhanced Delivery of Enhancer of Zeste Homolog-2 (EZH2) Inhibitor for the Treatment of Diffuse Intrinsic Pontine Glioma.
    Sasaki T; Katagi H; Goldman S; Becher OJ; Hashizume R
    Neurosurgery; 2020 Nov; 87(6):E680-E688. PubMed ID: 32674144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T2-weighted images are superior to other MR image types for the determination of diffuse intrinsic pontine glioma intratumoral heterogeneity.
    Harward S; Harrison Farber S; Malinzak M; Becher O; Thompson EM
    Childs Nerv Syst; 2018 Mar; 34(3):449-455. PubMed ID: 29151166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas.
    Wang JL; Barth RF; Cavaliere R; Puduvalli VK; Giglio P; Lonser RR; Elder JB
    PLoS One; 2020; 15(12):e0244383. PubMed ID: 33373402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A combined approach of convection-enhanced delivery of peptide nanofiber reservoir to prolong local DM1 retention for diffuse intrinsic pontine glioma treatment.
    Bellat V; Alcaina Y; Tung CH; Ting R; Michel AO; Souweidane M; Law B
    Neuro Oncol; 2020 Oct; 22(10):1495-1504. PubMed ID: 32301996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance imaging properties of convective delivery in diffuse intrinsic pontine gliomas.
    Chittiboina P; Heiss JD; Warren KE; Lonser RR
    J Neurosurg Pediatr; 2014 Mar; 13(3):276-82. PubMed ID: 24410126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal Monitoring of Gd-DTPA Following Convection Enhanced Delivery in the Brainstem.
    Tosi U; Souweidane MM
    World Neurosurg; 2020 May; 137():38-42. PubMed ID: 32028001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Novel Methodology for Applying Multivoxel MR Spectroscopy to Evaluate Convection-Enhanced Drug Delivery in Diffuse Intrinsic Pontine Gliomas.
    Guisado DI; Singh R; Minkowitz S; Zhou Z; Haque S; Peck KK; Young RJ; Tsiouris AJ; Souweidane MM; Thakur SB
    AJNR Am J Neuroradiol; 2016 Jul; 37(7):1367-73. PubMed ID: 26939629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical experience of convection-enhanced delivery (CED) of carboplatin and sodium valproate into the pons for the treatment of diffuse intrinsic pontine glioma (DIPG) in children and young adults after radiotherapy.
    Szychot E; Walker D; Collins P; Hyare H; Shankar A; Bienemann A; Hollingworth M; Gill S
    Int J Clin Oncol; 2021 Apr; 26(4):647-658. PubMed ID: 33575829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-PEGylated liposomes for convection-enhanced delivery of topotecan and gadodiamide in malignant glioma: initial experience.
    Grahn AY; Bankiewicz KS; Dugich-Djordjevic M; Bringas JR; Hadaczek P; Johnson GA; Eastman S; Luz M
    J Neurooncol; 2009 Nov; 95(2):185-197. PubMed ID: 19466380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats.
    Degen JW; Walbridge S; Vortmeyer AO; Oldfield EH; Lonser RR
    J Neurosurg; 2003 Nov; 99(5):893-8. PubMed ID: 14609170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Local delivery methods of therapeutic agents in the treatment of diffuse intrinsic brainstem gliomas.
    Goodwin CR; Xu R; Iyer R; Sankey EW; Liu A; Abu-Bonsrah N; Sarabia-Estrada R; Frazier JL; Sciubba DM; Jallo GI
    Clin Neurol Neurosurg; 2016 Mar; 142():120-127. PubMed ID: 26849840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential of theragnostic ¹²⁴I-8H9 convection-enhanced delivery in diffuse intrinsic pontine glioma.
    Luther N; Zhou Z; Zanzonico P; Cheung NK; Humm J; Edgar MA; Souweidane MM
    Neuro Oncol; 2014 Jun; 16(6):800-6. PubMed ID: 24526309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Convection-enhanced delivery into the rat brainstem.
    Sandberg DI; Edgar MA; Souweidane MM
    J Neurosurg; 2002 May; 96(5):885-91. PubMed ID: 12005396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Convection-enhanced Delivery of Therapeutics for Malignant Gliomas.
    Saito R; Tominaga T
    Neurol Med Chir (Tokyo); 2017 Jan; 57(1):8-16. PubMed ID: 27980285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infusion-related side-effects during convection enhanced delivery for brainstem-diffuse midline glioma/diffuse intrinsic pontine glioma.
    Hollingworth M; Zacharoulis S
    J Neurooncol; 2022 Sep; 159(2):417-424. PubMed ID: 35933568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-centre, single-arm, phase 1b trial.
    Spinazzi EF; Argenziano MG; Upadhyayula PS; Banu MA; Neira JA; Higgins DMO; Wu PB; Pereira B; Mahajan A; Humala N; Al-Dalahmah O; Zhao W; Save AV; Gill BJA; Boyett DM; Marie T; Furnari JL; Sudhakar TD; Stopka SA; Regan MS; Catania V; Good L; Zacharoulis S; Behl M; Petridis P; Jambawalikar S; Mintz A; Lignelli A; Agar NYR; Sims PA; Welch MR; Lassman AB; Iwamoto FM; D'Amico RS; Grinband J; Canoll P; Bruce JN
    Lancet Oncol; 2022 Nov; 23(11):1409-1418. PubMed ID: 36243020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early Cerebral Blood Volume Changes Predict Progression After Convection-Enhanced Delivery of Topotecan for Recurrent Malignant Glioma.
    Surapaneni K; Kennedy BC; Yanagihara TK; DeLaPaz R; Bruce JN
    World Neurosurg; 2015 Jul; 84(1):163-72. PubMed ID: 25772608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Convection-Enhanced Delivery in Children: Techniques and Applications.
    Aquilina K; Chakrapani A; Carr L; Kurian MA; Hargrave D
    Adv Tech Stand Neurosurg; 2022; 45():199-228. PubMed ID: 35976451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II evaluation of topotecan for pediatric central nervous system tumors.
    Blaney SM; Phillips PC; Packer RJ; Heideman RL; Berg SL; Adamson PC; Allen JC; Sallan SE; Jakacki RI; Lange BJ; Reaman GH; Horowitz ME; Poplack DG; Balis FM
    Cancer; 1996 Aug; 78(3):527-31. PubMed ID: 8697400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current status and advances to improving drug delivery in diffuse intrinsic pontine glioma.
    Arms LM; Duchatel RJ; Jackson ER; Sobrinho PG; Dun MD; Hua S
    J Control Release; 2024 Jun; 370():835-865. PubMed ID: 38744345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.